search
Back to results

Probability Ramp Control of Propofol for EGD

Primary Purpose

Gastrointestinal Disease

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Probability ramp control
Monitoring
Sponsored by
University of Pennsylvania
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Gastrointestinal Disease focused on measuring propofol sedation endoscopy

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • scheduled for elective EGD

Exclusion Criteria:

  • Unable to provide informed consent

Sites / Locations

  • Endoscopy Center, Perelman Center for Advanced Medicine

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Experimental

Arm Label

Monitoring

Probability ramp control

Arm Description

Standard of care sedation by CRNA using proposal with manual recording of drug dosing

Propofol titrated to deep sedation using PRC software.

Outcomes

Primary Outcome Measures

Number of Participants Requiring Adjustment in Propofol Dosing
Following initial sedation, an infusion rate for propofol is determined by the CRNA (control) or software (experimental). If this rate is appropriate for the duration of the brief procedure, no adjustment to the rate will be required. A greater requirement for rate changes suggests that the anesthesia provider needs to be immediately available to perform these adjustments.

Secondary Outcome Measures

Decrease in Minute Ventilation From Baseline
Minute ventilation as determined by respiratory inductance plethysmography from initiation of sedation until emergence.
Time Spent Below a Saturation of 80%
Number of seconds spent below saturation of 80%, reported as the total per group
Procedure Time
Time from endoscopic intubation until completion of the procedure. This is not really an outcome measure, but is used to assess balance between groups.

Full Information

First Posted
April 12, 2013
Last Updated
January 19, 2018
Sponsor
University of Pennsylvania
search

1. Study Identification

Unique Protocol Identification Number
NCT01838304
Brief Title
Probability Ramp Control of Propofol for EGD
Official Title
A Prospective, Randomized Comparison of Depth of Sedation With Propofol Titrated by Probability Ramp Control to Control by Anesthesia Providers During Esophagogastroduodenoscopy (EGD)
Study Type
Interventional

2. Study Status

Record Verification Date
January 2018
Overall Recruitment Status
Completed
Study Start Date
March 2013 (undefined)
Primary Completion Date
May 2013 (Actual)
Study Completion Date
May 2013 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Pennsylvania

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Endoscopic sedation requires titration of propofol to deep sedation without minimum overshoot into general anesthesia. This skill is demanding and acquired slowly. Probability Ramp Control (PRC) simplifies this by providing the clinician with a simple infusion sequence that permits gradual titration of propofol. The purpose of this study is to compare the performance of this technology to that of experienced anesthesia providers in endoscopic sedation.
Detailed Description
Administration of propofol to achieve a target of moderate sedation is a challenging task for which anesthesia providers receive minimal training. Undersedation results in a noncompliant patient, while oversedation results in airway obstruction, respiratory depression, and hypotension. Considerable variability in patient pharmacokinetics (the distribution of drug within the body) and pharmacodynamics (the translation of drug concentration to clinical effect) has been demonstrated. The skill of titrating propofol to the desired target and maintaining this state is slowly acquired in the clinical environment of the endoscopy center with frequent reliance on rescue skills. An automated system that facilitates this process would be useful. Pharmacokinetic models allow us to make predictions of the results of drug administration. If we know the age and size of the patient, we can determine a quantity of propofol that will attain a desired concentration at some point in the future (within the predictive accuracy of the model). If they are old, this is less than if they are young. If they are obese, this is more than if they are thin. By adjusting the dosing, we can achieve similar concentrations at a specified time in a wide range of patients. Pharmacodynamic models allow us to relate drug concentration to a probability of response. Sensitivity is a randomly distributed variable, and the cumulative probability of response to propofol is well represented by a sigmoid curve. While we do not know the concentration that will suffice for a given individual, we can determine the probability that this individual will lose responsiveness within an interval of concentrations. For example, the probability of loss of responsiveness between 1 µg/ml and 6 µg/ml is around 99%. For any given age and size, an infusion sequence can be determined so that we traverse this interval smoothly. The infusion sequence is determined by minimization of the difference between the simulated probability and the target (1). We predict that 90% of 50 year old 70 kg patients will lose responsiveness between one minute and three minutes after initiating the infusion, and 99% by five minutes. The infusion sequence for this patient is comprised of a bolus of 287 µg/kg followed by an initial infusion of 216 µg/kg/min, with an increase to 550 µg/kg/min after 147 seconds. By selecting the infusion sequence based on the age and size of the patient, all patients will track the same target line. These infusion rates are determined prior to initiation of sedation, and the clinician can verify that they are appropriate for the patient before beginning sedation. Once the endpoint of adequate sedation is observed, the effect site concentration associated with this endpoint is inferred, and the infusion that will maintain this concentration can be determined. This allows the clinical observation to be translated into an infusion rate, much as a driver accelerates to a desired speed and then engages the cruise control to maintain that speed. The intent of this study is to demonstrate equivalent safety and efficacy of PRC to control by a skilled clinician. References 1. Mandel JE, Sarraf E. The Variability of Response to Propofol Is Reduced When a Clinical Observation Is Incorporated in the Control: A Simulation Study. Anesthesia & Analgesia. 2012;114:1221-9.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Gastrointestinal Disease
Keywords
propofol sedation endoscopy

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
40 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Monitoring
Arm Type
Active Comparator
Arm Description
Standard of care sedation by CRNA using proposal with manual recording of drug dosing
Arm Title
Probability ramp control
Arm Type
Experimental
Arm Description
Propofol titrated to deep sedation using PRC software.
Intervention Type
Device
Intervention Name(s)
Probability ramp control
Intervention Description
Decision support software that calculates propofol doses appropriate for age and weight of the patient
Intervention Type
Device
Intervention Name(s)
Monitoring
Other Intervention Name(s)
Manual recording of drug doses determined by CRNA
Intervention Description
Manual recording of drug doses determined by CRNA
Primary Outcome Measure Information:
Title
Number of Participants Requiring Adjustment in Propofol Dosing
Description
Following initial sedation, an infusion rate for propofol is determined by the CRNA (control) or software (experimental). If this rate is appropriate for the duration of the brief procedure, no adjustment to the rate will be required. A greater requirement for rate changes suggests that the anesthesia provider needs to be immediately available to perform these adjustments.
Time Frame
Intraprocedure (average of 9 minutes)
Secondary Outcome Measure Information:
Title
Decrease in Minute Ventilation From Baseline
Description
Minute ventilation as determined by respiratory inductance plethysmography from initiation of sedation until emergence.
Time Frame
Duration of sedation (average of 25 minutes)
Title
Time Spent Below a Saturation of 80%
Description
Number of seconds spent below saturation of 80%, reported as the total per group
Time Frame
Duration of sedation (mean 25 minutes)
Title
Procedure Time
Description
Time from endoscopic intubation until completion of the procedure. This is not really an outcome measure, but is used to assess balance between groups.
Time Frame
Procedure time (average of 9 minutes)

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: scheduled for elective EGD Exclusion Criteria: Unable to provide informed consent
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jeff E Mandel, MD MS
Organizational Affiliation
University of Pennsylvania
Official's Role
Principal Investigator
Facility Information:
Facility Name
Endoscopy Center, Perelman Center for Advanced Medicine
City
Philadelphia
State/Province
Pennsylvania
ZIP/Postal Code
19104
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
22467886
Citation
Mandel JE, Sarraf E. The variability of response to propofol is reduced when a clinical observation is incorporated in the control: a simulation study. Anesth Analg. 2012 Jun;114(6):1221-9. doi: 10.1213/ANE.0b013e31824cb853. Epub 2012 Mar 30.
Results Reference
background

Learn more about this trial

Probability Ramp Control of Propofol for EGD

We'll reach out to this number within 24 hrs